Tokushima, Japan

Khosuke Fujiwara


Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1983-1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Khosuke Fujiwara: Innovator in Pharmaceutical Compounds

Introduction

Khosuke Fujiwara is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on isoquinolone compounds. His research has led to the development of compounds that have various therapeutic applications.

Latest Patents

Khosuke Fujiwara holds 2 patents. His latest patents include novel 1(2H)-isoquinolone compounds and their acid addition salts. These compounds are recognized for their potential as pharmaceutical agents, exhibiting activities such as anti-ulcer, increasing stomach mucous membrane blood flow, anti-hypertensive, analgesic, anti-histamine, anti-cholinergic, and gastric secretion inhibitory effects. The specific compounds are represented by a formula where various groups can be substituted to enhance their medicinal properties.

Career Highlights

Throughout his career, Khosuke Fujiwara has worked with prominent companies in the pharmaceutical industry. He has been associated with Taiho Pharmaceutical Company Limited and Maruko Seiyaku Co., Ltd. His work in these organizations has contributed to the advancement of pharmaceutical research and development.

Collaborations

Khosuke Fujiwara has collaborated with notable colleagues such as Shigeo Senda and Osamu Ohtani. These collaborations have further enriched his research and innovation in the field of pharmaceuticals.

Conclusion

Khosuke Fujiwara's contributions to the development of isoquinolone compounds highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic agents that can improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…